Showing results (261-270 of 610) with videos related to
Sort By:
Pageof 61
Journal of the National Cancer Institute|September 1, 1986
Tissue-type plasminogen activator in breast cancer: relationship with estradiol and progesterone receptorsM J Duffy, P O'Grady, J Simon, et al.Journal of Thrombosis and Haemostasis : JTH|April 4, 2007
A guide to murine fibrinolytic factor structure, function, assays, and genetic alterationsO Matsuo, H R Lijnen, S Ueshima, et al.Thrombosis and Haemostasis|October 1, 1981
Purification and characterization of the plasminogen activator secreted by a rat brain tumor cell line in cultureK Bykowska, D C Rijken, D CollenCurrent Gene Therapy|July 12, 2002
Viral vector-mediated gene therapy for hemophiliaT VandenDriessche, D Collen, M K ChuahStroke|September 26, 1997
Intravenous thrombolysis with recombinant staphylokinase versus tissue-type plasminogen activator in a rabbit embolic stroke modelS Vanderschueren, I Van Vlaenderen, D CollenBlood|January 1, 1988
Pharmacokinetics and thrombolytic properties of deletion mutants of human tissue-type plasminogen activator in rabbitsD Collen, J M Stassen, G LarsenEuropean Journal of Biochemistry|November 1, 1991
Effect of retinoic acid on the synthesis of tissue-type plasminogen activator and plasminogen activator inhibitor-1 in human endothelial cellsE A Thompson, L Nelles, D CollenThe Journal of Biological Chemistry|September 25, 1986
Purification and characterization of a novel inhibitor of urokinase from human urine. Quantitation and preliminary characterization in plasmaD C Stump, M Thienpont, D CollenThe Journal of Biological Chemistry|May 10, 1984
Involvement of heparin chain length in the heparin-catalyzed inhibition of thrombin by antithrombin IIIM Hoylaerts, W G Owen, D CollenThe Journal of Clinical Investigation|March 1, 1985
Generation in plasma of a fast-acting inhibitor of plasminogen activator in response to endotoxin stimulationM Colucci, J A Paramo, D CollenPageof 61